FDA Label for Ceo-two
View Indications, Usage & Precautions
Ceo-two Product Label
The following document was submitted to the FDA by the labeler of this product Beutlich Pharmaceuticals, Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredients
Potassium bitartrate, 0.9 g
Sodium bicarbonate, 0.6 g
Purposes
Laxative
Uses
- for relief of occasional constipation
- this product generally produces a bowel movement in 5 to 30 minutes
Warnings
For rectal use only
Keep Out Of Reach Of Children
If swallowed, get medical help or contact a poison control center right away
If Pregnant Or Breast-Feeding
ask a health professional before use
Directions
Adults and children 12 years of age and over: rectal dosage is one suppository containing 0.6 gram of sodium bicarbonate and 0.9 gram of potassium bitartrate in a single daily dose
Children under 12 years of age: consult a doctor
Detach one suppository from the strip; remove plastic wrapper. Moisten suppository by placing it under a water tap for 30 seconds, or in a cup of water for at least 10 seconds, before insertion. Insert rectally, bulb shape first, past largest diameter of suppository. Retain suppository as long as possible (usually 10 to 30 minutes) before defecating.
Other Information
- store at 20-25 °C (68-77 °F). Do not exceed 30 °C (86 °F).
- do not refrigerate
- for your protection, suppositories are individually wrapped in tamper-resistant film. Do not use if film is torn or open when purchased.
- save this carton for future reference
Inactive Ingredient
polyethylene glycol
Questions Or Comments?
1-800-238-8542
M-F: 8:00 a.m. - 4:30 p.m. ET
Prinicipal Display Panel - 54 Count
CEO-TWO Laxative Suppositories
Box of 2:
Box of 6:
Box of 54:
* Please review the disclaimer below.